Replies to post #755206 on NorthWest Biotherapeutics Inc (NWBO)

[Jackxkr]

I hope your guess is wrong. If they can't attract a partner after approval something is insanely wrong. I hope they are not concentrating on the lawsuit because they feel they are not gonna get approval and need the cash for another swing at the plate , whatever or wherever that is.

[Am813]

This doesn't really make sense. A. They likely have a contingency fee contract with the firm and B. The suit is in the hands of the lawyers, there literally isnt anything for the company to "focus" on.

[flipper44]

If I had to guess, the MTD is all they are hoping comes in ahead of any MAA approval decision. The damages are based upon the times listed in the complaint, and that does not include now. I think you might not know that. However, the MMs major defense, although misguided, is that dcvax-l is a failed therapy marketing application.

Therefore, NWBO would more than likely want approval in their back pocket to 100% refute MMs’ primary argument going forward. I think NWBO are counting on the Judge to follow the law and not look beyond the complaint, and, beyond that, maybe rule on the MTD before any MAA approval decision. This would effectively free Ms. Posner to go toward trial with a full head of steam, and NWBO to go towards commercial launch, ramp, automation, trials, etc with a full head of steam, if they have third party funding aside from any lawsuit anticipatory funding.

[dennisdave]

I had to guess, there is not a strong partner lined up that will bring in any substantial cash to fund operations in the near term.

I will tell you Mike, I heard very differently from a large shareholder in my group... and its all depending on approval.

Also. NWBO (and Linda's precious Advent) will not survive another year with all the plans as laid out in the last 10Q including a very expensive joint trial + commercialization + Advent + Flaskworks+ NWBO staff if they have not arranged a large financial injection

If I had to guess - and I want to stress, this is my speculation - the company is far more focused on the lawsuit than any of us retail investors would be comfortable with. Like....they are way more interested in the lawsuit than they are the MAA at this juncture.

You really guessed wrong here. Management are borderline criminals but they are not that stupid to count and depend on a maybe yes maybe no settlement to fund all the 10Q plans + + as described

[branster]

FeMike, so one good thing is a cash settlement would bring an end to the dilution while revenue's pick up assuming approval, however, a cash settlement may not be likely until 2026 so what do we have for cash outside us investors funneling in our hard earned money??

That would be a partnership with a cash infusion. Everyone knows dilution probably is the lead culprit in SP slide, so that must be stopped before the SP can recover and stabilize, else we a pop and slowly SP rolls backwards overtime after approval. It will take some time before revenue's are obtained and posted in the Q's, only then will we know what out net becomes after expenses to stop the dilution, We already know on a monthly basis how much the outstanding share increases, about 20 million per month at these prices, so net $5 Million cash or there abouts.